Medical Marijuana (MMJ)

Two senate bills, SB 302 and SB 700, were passed to California Governor Newsom where they were signed into law, expanding cannabis rights for both patients and employees.

The ANA has formally announced their recognition of cannabis nursing as a specialty nursing practice.

In this new interview series, we sit down with several speakers from 2023 Cannabis Science Conference events to learn about their expertise and backgrounds in the cannabis industry. Join us to learn more about Dr. Peter Grinspoon, Jini Glaros, Dr. Miyabe Shields, and Adam Jacques.

See the program overview for the upcoming Cannabis Science Conference Fall in Providence, Rhode Island September 20-22nd.

The seventh installment in the series looks at cannabis use in people over 50 years old, the stigma surrounding cannabis use, and the concept of ‘plants over pills.’

The chairman of Alabama’s Medical Cannabis Commission (AMCC), Dr. Steve Stokes, has resigned from his position.

Americans for Safe Access, the nation’s largest member-based organization promoting safe access to medical cannabis, recently released a detailed report on how disparities in state cannabis testing programs affect the health of patients.

Our sister publication, Oncology Nursing News, interviewed two authors of a recent survey presented to nurses in California who worked with patients who used medical cannabis.

Cannabis Science Conference Spring was held in Portland, Oregon from April 19-21, 2023. Here we provide a few highlights from the event.

The webinar "Cannabis and Dementia: Unlocking the Potential" was held on June 14, 2023, and featured four panelists’ experiences treating dementia symptoms with cannabis.

Filmed onsite at Cannabis Science Conference Spring 2023, Eloise Theisen shares perspectives and insider information from her profession.

Dustin Sulak, DO, founder of Healer and Integr8 Health, served as one of the keynote speakers at Cannabis Science Conference Spring 2023.

A civil lawsuit filed in Arkansas by a medical cannabis patient alleges that three cannabis growers and one testing laboratory inflated the amount of tetrahydrocannabinol (THC) in numerous cannabis products.

Recently, the University of Oxford began an international study to examine the potential therapeutic benefits of cannabidiol (CBD) in treating psychosis or psychotic symptoms.

This study, which evaluated the potential of a well-designed unidirectional aseptic processing approach to both hydrocarbon and supercritical carbon dioxide extract manufacturing, suggests that the extraction process is capable of deactivating or removing the tested microbial contaminants when highly contaminated Cannabis spp. Inflorescence is used as feed material.

In this interview, Abbey Roudebush, Director of Government Affairs for Americans for Safe Access (ASA), explains the goals of ASA and provides an in-depth analysis of their annual State of the States report.

In this article, regulatory requirements are explored as they are meant to create confidence that cannabis and cannabis-infused products are safe to use.

The Cannabis Center of Excellence, Inc., Medicinal Genomics, and UMass Dartmouth have established the Healthcare Provider Knowledge, Attitudes, Practices Related to Medical Cannabis Research Study to help better understand the experiences of healthcare providers have seen with medical cannabis.

In this interview, learn about Nicole DiMonda’s incredible story and Jaime Brambila’s research efforts to document her case and help the lives of other cancer patients.

United Nations hold historic vote announcing cannabis's Schedule IV removal from the 1961 Single Convention on Narcotics.

The proceeds raised from the special Veterans Day webcast will help support the families of America's fallen military heroes.

Welcome to the first edition of Cannabis Patient Care!

A report on the findings from the anonymous 2019 Veterans Health and Medical Cannabis Study, which was a national and Massachusetts-focused research study led by Dr. Marion McNabb, Stephen Mandile, and Dr. Stephen White.

Stephen Mandile—veteran, cannabis patient, and advocate—shares his personal experience with medical cannabis and how it has given him a new mission to help other veterans gain access to this plant.

An in-depth conversation with Dr. Staci Gruber, Director of the Cognitive and Clinical Neuroimaging Core, Director of Marijuana Investigations for Neuroscientific Discovery (MIND) at McLean Hospital, and Associate Professor of Psychiatry at Harvard Medical School on her interest in medical cannabis and the medical cannabis research areas that MIND is focusing on for veterans and beyond.